https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-07-20 / J Gastrointest Surg 2013 Sep;17(9):1609-17
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-07-20 / J Gastrointest Surg 2013 Sep;17(9):1609-172013-07-20 00:00:002024-08-26 09:28:16Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-07-13 / Ann. Surg. Oncol. 2013 Oct;20(10):3233-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-07-13 / Ann. Surg. Oncol. 2013 Oct;20(10):3233-92013-07-13 00:00:002019-02-15 08:50:02Response to HER-2 pulsed DC1 vaccines is predicted by both HER-2 and estrogen receptor expression in DCIS
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-07-09 / Clin. Cancer Res. 2013 Sep;19(17):4801-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-07-09 / Clin. Cancer Res. 2013 Sep;19(17):4801-152013-07-09 00:00:002019-04-03 09:09:02A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-07-02 / Biology (Basel) 2013 Jul;2(3):936-75
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-07-02 / Biology (Basel) 2013 Jul;2(3):936-752013-07-02 00:00:002021-11-15 16:56:11Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-07-02 / Cancer Immunol. Immunother. 2013 Sep;62(9):1499-509
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-07-02 / Cancer Immunol. Immunother. 2013 Sep;62(9):1499-5092013-07-02 00:00:002019-02-15 08:46:28Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
